Sangeeta Narwal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sangeeta Narwal has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Bhagwati Devi
2 shared publicationsTilak Dhanda
2 shared publications- Nidhi Rani
Chitkara College of Pharmacy, Chitkara University, Punjab, India
1 shared publication - P. Kumari
School of Pharmaceutical Sciences, Starex University
1 shared publication - P. Sharma
Shri Kirishna AYUSH University
1 shared publication - Prabhakar Kumar Verma
Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India
1 shared publication
Latest Publications
- 25 April 2026
- Published by IRBIS in Epilepsy and paroxysmal conditions
- Vol. 18 (1) , 48-61
A new twist in the story of neurochemical communication: co-transmission
A substantial amount of progress has been made in the field of neurohumoral transmission, which has led to the disclosure of precise details regarding the communication mechanisms that occur within the neurological system. This review article gives an extensive analysis of neurohumoral transmission, focusing on the evolving concept of co-transmission and its implications for understanding psychiatric disorders in adolescents. It first provides details on classical neurotransmitters: acetylcholine, serotonin, dopamine, glutamate, and gamma-aminobutyric acid and their role in neuronal communication. Recent research findings have shown that many neurons have the ability to simultaneously release one or more than one neurotransmitter, a phenomenon termed as co-transmission and seem to add complexity to how signals are processed through the nervous system. This phenomenon raises important implications in adolescent psychiatric disorders such as depression, anxiety, schizophrenia, attention deficit hyperactivity disorder, and autism spectrum disorder, which inevitably worsen during this stage of critical development. Recent findings suggest that diminished neurotransmitter co-transmission in certain regions, such as the prefrontal cortex, might be associated with some of these impaired cognitive and emotional regulatory processes. Understanding these complex mechanisms might provide insights into the development of effective treatments targeting several neurotransmitter systems simultaneously-especially during adolescence, when the brain is particularly sensitive to chemical interactions. This review integrates recent findings into a discussion on their implications for treatment strategies, and it hints at new pharmacological interventions directed at modulating co-transmission pathways that can enhance mental health outcomes in adolescents.
- 25 April 2026
- Published by IRBIS in Epilepsy and paroxysmal conditions
- Vol. 18 (1) , 48-61
A new twist in the story of neurochemical communication: co-transmission
A substantial amount of progress has been made in the field of neurohumoral transmission, which has led to the disclosure of precise details regarding the communication mechanisms that occur within the neurological system. This review article gives an extensive analysis of neurohumoral transmission, focusing on the evolving concept of co-transmission and its implications for understanding psychiatric disorders in adolescents. It first provides details on classical neurotransmitters: acetylcholine, serotonin, dopamine, glutamate, and gamma-aminobutyric acid and their role in neuronal communication. Recent research findings have shown that many neurons have the ability to simultaneously release one or more than one neurotransmitter, a phenomenon termed as co-transmission and seem to add complexity to how signals are processed through the nervous system. This phenomenon raises important implications in adolescent psychiatric disorders such as depression, anxiety, schizophrenia, attention deficit hyperactivity disorder, and autism spectrum disorder, which inevitably worsen during this stage of critical development. Recent findings suggest that diminished neurotransmitter co-transmission in certain regions, such as the prefrontal cortex, might be associated with some of these impaired cognitive and emotional regulatory processes. Understanding these complex mechanisms might provide insights into the development of effective treatments targeting several neurotransmitter systems simultaneously-especially during adolescence, when the brain is particularly sensitive to chemical interactions. This review integrates recent findings into a discussion on their implications for treatment strategies, and it hints at new pharmacological interventions directed at modulating co-transmission pathways that can enhance mental health outcomes in adolescents.
- 20 January 2024
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1303
Exploring Chalcone Derivatives: Synthesis and Their Therapeutic Potential
- 20 January 2024
- Published by Elsevier in Journal of Molecular Structure
- Vol. 1303
Exploring Chalcone Derivatives: Synthesis and Their Therapeutic Potential
- Open Access
- 9 June 2017
- Published by Springer Nature in BMC Chemistry
- Vol. 11 (1) , 52
Design, synthesis and antimicrobial evaluation of pyrimidin-2-ol/thiol/amine analogues
Pyrimidine is an aromatic heterocyclic moiety containing nitrogen atom at 1st and 3rd positions and play an important role to forms the central core for different necessity of biological active compounds, from this facts, we have designed and synthesized a new class of pyrimidin-2-ol/thiol/amine derivatives and screened for its in vitro antimicrobial activity. The synthesized pyrimidine derivatives were confirmed by IR, 1H/13C-NMR, Mass spectral studies and evaluated for their in vitro antimicrobial potential against Gram positive (S. aureus and B. subtilis), Gram negative (E. coli, P. aeruginosa and S. enterica) bacterial strains and fungal strain (C. albicans and A. niger) by tube dilution method and recorded minimum inhibitory concentration in µM/ml. The MBC and MFC values represent the lowest concentration of compound that produces in the range of 96–98% end point reduction of the used test bacterial and fungal species. In general all synthesized derivatives exhibited good antimicrobial activity. Among them, compounds 2, 5, 10, 11 and 12 have significant antimicrobial activity against used bacterial and fungal strains and also found to be more active than the standard drugs. Graphical abstract Pyrimidine is an aromatic heterocyclic moiety containing nitrogen atom at 1st and 3rd positions and play an important role to forms the central core for different necessity of biological active compounds, from this facts, we have designed and synthesized a new class of pyrimidin-2-ol/thiol/amine derivatives and screened for its in vitro antimicrobial activity. The synthesized pyrimidine derivatives were confirmed by IR, 1H/13C-NMR, Mass spectral studies and evaluated for their in vitro antimicrobial potential against Gram positive (S. aureus and B. subtilis), Gram negative (E. coli, P. aeruginosa and S. enterica) bacterial strains and fungal strain (C. albicans and A. niger) by tube dilution method and recorded minimum inhibitory concentration in µM/ml. The MBC and MFC values represent the lowest concentration of compound that produces in the range of 96–98% end point reduction of the used test bacterial and fungal species.
- 9 June 2017
- Published by Springer Nature in BMC Chemistry
- Vol. 11 (1) , 52
Open AccessDesign, synthesis and antimicrobial evaluation of pyrimidin-2-ol/thiol/amine analogues
Pyrimidine is an aromatic heterocyclic moiety containing nitrogen atom at 1st and 3rd positions and play an important role to forms the central core for different necessity of biological active compounds, from this facts, we have designed and synthesized a new class of pyrimidin-2-ol/thiol/amine derivatives and screened for its in vitro antimicrobial activity. The synthesized pyrimidine derivatives were confirmed by IR, 1H/13C-NMR, Mass spectral studies and evaluated for their in vitro antimicrobial potential against Gram positive (S. aureus and B. subtilis), Gram negative (E. coli, P. aeruginosa and S. enterica) bacterial strains and fungal strain (C. albicans and A. niger) by tube dilution method and recorded minimum inhibitory concentration in µM/ml. The MBC and MFC values represent the lowest concentration of compound that produces in the range of 96–98% end point reduction of the used test bacterial and fungal species. In general all synthesized derivatives exhibited good antimicrobial activity. Among them, compounds 2, 5, 10, 11 and 12 have significant antimicrobial activity against used bacterial and fungal strains and also found to be more active than the standard drugs. Graphical abstract Pyrimidine is an aromatic heterocyclic moiety containing nitrogen atom at 1st and 3rd positions and play an important role to forms the central core for different necessity of biological active compounds, from this facts, we have designed and synthesized a new class of pyrimidin-2-ol/thiol/amine derivatives and screened for its in vitro antimicrobial activity. The synthesized pyrimidine derivatives were confirmed by IR, 1H/13C-NMR, Mass spectral studies and evaluated for their in vitro antimicrobial potential against Gram positive (S. aureus and B. subtilis), Gram negative (E. coli, P. aeruginosa and S. enterica) bacterial strains and fungal strain (C. albicans and A. niger) by tube dilution method and recorded minimum inhibitory concentration in µM/ml. The MBC and MFC values represent the lowest concentration of compound that produces in the range of 96–98% end point reduction of the used test bacterial and fungal species.